© 2025 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WEDW-FM · WNPR · WPKT · WRLI-FM
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Bayer Makes $62 Billion Play For Monsanto

ARI SHAPIRO, HOST:

Bayer may be best known as a company that makes aspirin. The German conglomerate also sells a lot of other products, though, including scenes and chemicals for farms. Today, Bayer announced that it wants to grow further by acquiring St. Louis-based Monsanto for $62 billion dollars. NPR's Jim Zarroli reports.

JIM ZARROLI, BYLINE: Bayer confirmed the news that was leaked to the press last week. It's made an offer to buy Monsanto, the agribusiness giant known around the world as a maker of genetically modified seeds. Monsanto hasn't yet responded, but if the deal goes through, it would create the world's largest provider of seeds and agricultural chemicals. Werner Baumann is Bayer's CEO.

WERNER BAUMANN: The proposed transaction is driven by a strong belief that while our industry has take on enormous challenges, this combination is a powerful response.

ZARROLI: The deal comes at a time when big mergers are radically reshaping the chemical industry. Dow Chemical and DuPont announced a $130 billion dollar-deal last December. At the same time, a decline in commodity prices and a drop in farm income is cutting into company profits. Radhakrishnan Gopalan is an associate professor of business at Washington University in St. Louis.

RADHAKRISHNAN GOPALAN: Monsanto is going through some difficult times given that the agriculture sector is not doing too bad. Their stock has fallen significantly. They are retrenching.

ZARROLI: Bayer officials argue that merging would save the company's money and make them more competitive. But the deal faces an uncertain regulatory environment in the U.S. and Europe. There is little product overlap between Bayer and Monsanto, but the deal would give the combined company greater control over the products farmers buy, and the deal faces skepticism on Wall Street.

Some investors are concerned that Bayer is taking on more debt than is good for it. And they worry that Bayer may have to sweeten the deal to gain Monsanto's support. Shares of Bayer were down today after the details of the deal were announced. Jim Zarroli, NPR News, New York. Transcript provided by NPR, Copyright NPR.

Jim Zarroli is an NPR correspondent based in New York. He covers economics and business news.

Federal funding is gone.

Congress has eliminated all funding for public media.

That means $2.1 million per year that Connecticut Public relied on to deliver you news, information, and entertainment programs you enjoyed is gone.

The future of public media is in your hands.

All donations are appreciated, but we ask in this moment you consider starting a monthly gift as a Sustainer to help replace what’s been lost.

SOMOS CONNECTICUT is an initiative from Connecticut Public, the state’s local NPR and PBS station, to elevate Latino stories and expand programming that uplifts and informs our Latino communities. Visit CTPublic.org/latino for more stories and resources. For updates, sign up for the SOMOS CONNECTICUT newsletter at ctpublic.org/newsletters.

SOMOS CONNECTICUT es una iniciativa de Connecticut Public, la emisora local de NPR y PBS del estado, que busca elevar nuestras historias latinas y expandir programación que alza y informa nuestras comunidades latinas locales. Visita CTPublic.org/latino para más reportajes y recursos. Para noticias, suscríbase a nuestro boletín informativo en ctpublic.org/newsletters.

Federal funding is gone.

Congress has eliminated all funding for public media.

That means $2.1 million per year that Connecticut Public relied on to deliver you news, information, and entertainment programs you enjoyed is gone.

The future of public media is in your hands.

All donations are appreciated, but we ask in this moment you consider starting a monthly gift as a Sustainer to help replace what’s been lost.